Metraipolis › archive › dc_2eb3073c0bba
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis — Europe PMC PMID:42297776
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42297776
- DOI
- 10.1038/s41467-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T11:11:10.915Z
- SHA-256 of the archived text
2bb61f0bbf582f84ab4023226d0a1a5c3e34bbd1ab8b2e935d8739d99e4a99dc- Stable URL of this page
https://metraipolis.com/documento/dc_2eb3073c0bba
How to cite
Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis — Europe PMC PMID:42297776 — Europe PMC (en), https://europepmc.org/article/MED/42297776 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2eb3073c0bba (Metraipolis archive dc_2eb3073c0bba, sha256 2bb61f0bbf582f84ab4023226d0a1a5c3e34bbd1ab8b2e935d8739d99e4a99dc)
BibTeX
@misc{dc2eb3073c0bba,
title = {Oncogenic KRAS-driven type I interferon signalling primes pancreatic cancer for necroptosis — Europe PMC PMID:42297776},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42297776},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2eb3073c0bba; sha256 2bb61f0bbf582f84ab4023226d0a1a5c3e34bbd1ab8b2e935d8739d99e4a99dc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42297776. Agents can read the archived copy with the MCP tool read_document.